We are live on ! Find out more
LA

Lynch & Associates Portfolio holdings

AUM $573M
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+21.74%
3 Year Est. Return
+62.9%
5 Year Est. Return
+80.86%
10 Year Est. Return
+253.75%
AUM
$175M
AUM Growth
+$5.59M
Cap. Flow
-$788K
Cap. Flow %
-0.45%
Top 10 Hldgs %
38.78%
Holding
97
New
1
Increased
53
Reduced
21
Closed
6

Sector Composition

Rank Sector Weight
1 Industrials 20.82%
2 Healthcare 16.16%
3 Miscellaneous 10.56%
4 Consumer Staples 10.53%
5 Energy 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEY icon
76
KeyCorp
KEY
$23.5B
$360K 0.21%
25,100
-200
-0.8% -$2.76K
AA icon
77
Alcoa
AA
$13.5B
$340K 0.19%
9,503
+104
+1% +$3.41K
HBAN icon
78
Huntington Bancshares
HBAN
$34.1B
$331K 0.19%
34,700
AVA icon
79
Avista
AVA
$3.16B
$330K 0.19%
9,850
+150
+2% +$4.75K
TE
80
DELISTED
TECO ENERGY INC
TE
$329K 0.19%
17,822
+200
+1% +$3.52K
HD icon
81
Home Depot
HD
$328B
$324K 0.19%
4,000
RF icon
82
Regions Financial
RF
$25.9B
$291K 0.17%
27,414
+1,867
+7% +$19.5K
BCR
83
DELISTED
CR Bard Inc.
BCR
$286K 0.16%
2,000
RAI
84
DELISTED
Reynolds American Inc
RAI
$233K 0.13%
7,732
+88
+1% +$2.52K
XLB icon
85
State Street Materials Select Sector SPDR ETF
XLB
$8.82B
$229K 0.13%
9,230
+320
+4% +$7.72K
VTI icon
86
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
$214K 0.12%
2,100
FSK icon
87
FS KKR Capital
FSK
$3.38B
$205K 0.12%
+4,808
New +$199K
CGEN icon
88
Compugen
CGEN
$261M
$90K 0.05%
10,000
NAVB
89
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$27K 0.02%
900
BRBI
90
DELISTED
BLUE RIVER BANCSHARES INC
BRBI
$1K ﹤0.01%
124,708
AJG icon
91
Arthur J. Gallagher & Co
AJG
$66.7B
-20,856
Closed -$992K
DRI icon
92
Darden Restaurants
DRI
$24B
-9,686
Closed -$439K
MAS icon
93
Masco
MAS
$14.4B
-11,261
Closed -$220K
WSBF icon
94
Waterstone Financial
WSBF
$379M
-11,109
Closed -$115K
CWAY
95
DELISTED
Coastway Bancorp, Inc.
CWAY
-15,000
Closed -$154K
BEAM
96
DELISTED
BEAM INC COM STK (DE)
BEAM
-4,596
Closed -$383K

Similar funds

Lynch & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Lynch & Associates held 97 positions worth $175M, up 3.3% from $170M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Lynch & Associates's Q2 2014 filing shows 1 new, 53 increased, 21 reduced and 6 closed positions. Its largest new stake was FS KKR Capital: 4,808 shares worth $205K. The largest sale was Arthur J. Gallagher & Co, an estimated $992K.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Lynch & Associates's largest Q2 2014 buy was FS KKR Capital: 4,808 shares worth $205K.
  • Lynch & Associates added most to Intel in Q2 2014, an estimated $281K increase.
  • Lynch & Associates's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $664K.
  • Lynch & Associates fully exited Arthur J. Gallagher & Co in Q2 2014, selling an estimated $992K.
  • Lynch & Associates's ten largest holdings make up 39% of its $175M portfolio in Q2 2014.
  • Lynch & Associates opened 1 new position and closed 6 in Q2 2014.
  • Lynch & Associates's portfolio value rose 3.3% quarter-over-quarter to $175M.

Based on Lynch & Associates's 13F filing for Q2 2014, filed 15 Jul 2014.